A controversial proposal for the World Trade Organization to temporarily waive intellectual property rights and provide greater access to Covid-19 medical products appears unlikely to pass, according to people tracking the latest round of meetings at the global agency.
Despite a year-long debate, disagreement remains on the fundamental question of whether a waiver is appropriate and the most effective way to tackle inequitable distribution of Covid-19 vaccines and treatments, according to a trade official who is based in Geneva, Switzerland, where talks are being held. The WTO needs consensus from all of its 164 members for the proposal to be adopted.
Create a display name to comment
This name will appear with your comment